Cargando…
Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange
Ras mutations are the oncogenic drivers of many human cancers and yet there are still no approved Ras-targeted cancer therapies. Inhibition of Ras nucleotide exchange is a promising new approach but better understanding of this mechanism of action is needed. Here we describe an antibody mimetic, DAR...
Autores principales: | Guillard, Sandrine, Kolasinska-Zwierz, Paulina, Debreczeni, Judit, Breed, Jason, Zhang, Jing, Bery, Nicolas, Marwood, Rose, Tart, Jon, Overman, Ross, Stocki, Pawel, Mistry, Bina, Phillips, Christopher, Rabbitts, Terence, Jackson, Ronald, Minter, Ralph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519984/ https://www.ncbi.nlm.nih.gov/pubmed/28706291 http://dx.doi.org/10.1038/ncomms16111 |
Ejemplares similares
-
KRAS-specific inhibition using a DARPin binding to a site in the allosteric lobe
por: Bery, Nicolas, et al.
Publicado: (2019) -
BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
por: Bery, Nicolas, et al.
Publicado: (2018) -
Correction: BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
por: Bery, Nicolas, et al.
Publicado: (2018) -
Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds
por: Cruz-Migoni, Abimael, et al.
Publicado: (2019) -
DARPins: Promising Scaffolds for Theranostics
por: Shilova, O. N., et al.
Publicado: (2019)